Sonnet BioTherapeutics Holdings, Inc. Quarterly Depreciation in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q4 2023.
  • Sonnet BioTherapeutics Holdings, Inc. Depreciation for the quarter ending December 31, 2023 was $3.21K, unchanged year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2023 was $12.8K, unchanged from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2022 was $12.8K, a 3.12% increase from 2021.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2021 was $12.5K, a 50.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $3.21K $0 0% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q4 2022 $3.21K -$1 -0.03% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q4 2021 $3.21K +$131 +4.25% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q4 2020 $3.08K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-08
Q3 2019 $1.68M $419K -$18K -4.12% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $1.7M $432K +$40K +10.2% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $1.66M $423K +$16K +3.93% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $1.64M $407K Oct 1, 2018 Dec 31, 2018 10-K 2019-04-01
Q3 2018 $437K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $392K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $407K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q2 2015 $376K -$198K -34.4% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q2 2014 $574K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q3 2013 $124K +$31K +33.4% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-15
Q1 2013 $57K $124K +$48.2K +63.2% Jan 1, 2013 Mar 31, 2013 10-Q 2013-08-12
Q4 2012 $8.77K -$243K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 $92.8K +$90.2K +3593% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 $82.7K +$80.2K +3191% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $76.3K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 $2.51K Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 $2.51K Apr 1, 2011 Jun 30, 2011 10-Q/A 2013-01-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.